Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.3%
    Check dated 2025-06-22T06:29:50.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-15T02:46:12.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-08T01:40:30.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.4%
    Check dated 2025-05-31T20:35:24.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.15.0 to v2.16.0. Additionally, options to 'Save' and 'Download' have been added.
    Difference
    0.1%
    Check dated 2025-05-23T17:36:25.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed trial information and inclusion criteria for a clinical study on talazoparib, while adding new identifiers and collaborators.
    Difference
    8%
    Check dated 2025-04-22T09:42:00.000Z thumbnail image

Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.